← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
176	SGTX 176 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	–	–	–	–
177	SLBT 177 SL Science Holding Ltd SLBT $864M	–	–	–	–
178	178 Solid Biosciences SLDB $604M	–	–	–	–
179	179 Silence Therapeutics SLN $546M	–	–	–	–
180	180 Senti Biosciences Holdings SNTI $7.36M	–	–	–	–
181	181 SOPHiA GENETICS SOPH $593M	–	–	–	–
182	SQZ 182 DELISTED SQZ Biotechnologies Company SQZ	–	–	–	–
183	183 Stoke Therapeutics STOK $1.56B	–	–	–	–
184	184 DELISTED Telesis Bio, Inc. Common Stock TBIO	–	–	–	–
185	TCBP 185 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	–	–	–	–
186	TCRR 186 DELISTED TCR2 Therapeutics Inc. Common Stock TCRR	–	–	–	–
187	187 TScan Therapeutics TCRX $16.1M	–	–	–	–
188	188 Instil Bio TIL $41.5M	–	–	–	–
189	189 Tenaya Therapeutics TNYA $88.2M	–	–	–	–
190	190 DELISTED Turnstone Biologics TSBX	–	–	–	–
191	191 Taysha Gene Therapies TSHA $1.19B	–	–	–	–
192	192 DELISTED 2seventy bio TSVT	–	–	–	–
193	193 Twist Bioscience TWST $8.84B	–	–	–	–
194	194 10x Genomics TXG $9.08B	–	–	–	–
195	195 DELISTED Verve Therapeutics VERV	–	–	–	–
196	196 Voyager Therapeutics VYGR $124M	–	–	–	–
197	197 GeneDx Holdings WGS $1.95B	–	–	–	–
198	198 Wave Life Sciences WVE $617M	–	–	–	–
199	XDNA 199 DELISTED Strategic Trust Kelly CRISPR & Gene Editing Technology ETF XDNA	–	–	–	–